{ 128件 }
Kuniyuki Aso, Michihito Kono, Nobuya Abe, Yuichiro Fujieda, Masaru Kato, Tatsuya Atsumi Anti-ganglionic nicotinic acetylcholine receptor α3 subunit antibody as a potential biomarker associated with lupus enteritis Modern Rheumatology, in press
IF: 3.023
Shuhei Takeyama, Nobuya Abe, Tatsuya Atsumi.
Autosplenectomy.
European Journal of Internal Medicine 2022, in press.
IF 4.624
Abe N, Kono Michihito, Kono Michihiro, Ohnishi N, Sato T, Tarumi M, Yoshimura M, Sato T, Karino K, Shimizu Y, Fujieda Y, Kato M, Hasebe R, Oku K, Murakami M, Atsumi T.
Glycogen synthase kinase 3β/CCR6-positive bone marrow cells correlate with disease activity in multicentric Castleman disease-TAFRO.
Br. J. Haematol. in press.
IF=6.998
Atsumi T, Tanaka Y, Matsubara T, Amano K, Ishiguro N, Sugiyama E, Yamaoka K, Westhovens R, Ching D, Messina OD, Burmester GR, Bartok B, Pechonkina A, Kondo S, Yin Z, Guo Y, Tasset C, Sundy JS, Takeuchi T Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3) Modern Rheumatology, in press.
IF: 3.023
Sugawara M, Fujieda Y, Noguchi A, Tanimura S, Shimizu Y, Nakagawa I, Yoshimura M, Abe N, Kono M, Kato M, Oku K, Amengual O, Yokota I, Takahashi H, Atsumi T.
Prediction of non-responder to JAK inhibitors in patients with rheumatoid arthritis: a preliminary study with integrative cluster analysis.
Clin Exp Rheumatol. 2021
IF: 3.319
Nagasaka K, Kaname S, Amano K, Kato M, Katsumata Y, Komagata Y, Sada K, Tanaka E, Tamura N, Dobashi H, Nanki T, Harabuchi Y, Bando M, Homma S, Wada T, Harigai M.
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour, and Welfare Database.
Modern Rheumatology. in press.
IF: 2.113
令和2年度北海道大学医学部エクセレント・ティーチャー（最優秀賞） 加藤 将先生
Nobuya Abe, Michihito Kono, Ikuko Iwata, Tatsuya Atsumi. Lupus-induced autoimmune chloride channelopathy like myotonia congenita, successfully treated with immunosuppression.
Rheumatology, in press
IF=7.580
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.
JAMA. 2021 Jun 1;325(21):2178-2187.
IF: 45.540
JCR2021 近未来のリウマチ医セッション 優秀ポスター賞 平石 直幹さん（学生） （指導医：垂水 政人先生）